Skip to content

Dr. Gosia Domagalska: Outwitting Leishmania

In the quiet corridors of the Institute of Tropical Medicine (ITM) in Antwerp, Belgium, Dr. Malgorzata “Gosia” Domagalska is leading the fight against one of the world’s most neglected yet devastating diseases: leishmaniasis. As head of ITM’s newly established Unit of Experimental Parasitology, she has dedicated her career to understanding how parasites adapt, survive, and outwit medicine.

Domagalska’s path to parasitology was anything but straightforward. Trained as a geneticist, she earned her PhD in Plant Genetics at the Max Planck Institute in Cologne, followed by a Marie Curie Fellowship at the University of York. Early on, her research focused on plant development and hormones. But a shift came when she joined ITM in 2015: “This work is compelling not just scientifically, but socially,” she has said.

Leishmaniasis – Plain and Simple

Leishmaniasis is a parasitic disease that few people have heard of, but one you definitely don’t want to catch. Caused by Leishmania parasites and spread by the bite of female sand flies, it can silently linger in the body for years or surface in devastating ways, from painful skin sores to organ damage that can be fatal. The disease affects both humans and dogs, with our canine companions often acting as unwitting reservoirs that keep the infection circulating.

As climate change expands the habitat of sand flies into new regions, the threat of leishmaniasis continues to grow. With no reliable cure and limited vaccine options, prevention is key. Protecting yourself and your pets with repellents, protective gear, and vigilance is the most effective way to guard against this serious but often overlooked disease.

Sand Flies: The Silent Biters Spreading A Deadly Disease

Phlebotomine sand flies are notorious biters. They not only cause great irritation but are also capable of spreading a deadly disease – visceral leishmaniasis.

While the World Health Organization states that currently 1 billion people live in areas endemic for leishmaniasis and at risk of contracting the disease, a recent study using a statistical model, predicted that visceral leishmaniasis (VL) is undergoing geographic expansion and 5.3 billion people could be at risk of acquiring the disease in the future.

Leishmaniasis currently occurs in approximately 90 countries. These countries are located in the warmer climates where sand flies thrive: in the tropics, subtropics, and in Southern Europe. Climate change and other variations in the environment have the potential to expand the geographical range of where sand flies can live and therefore where the disease can infiltrate the human population.

Epidemiology of Leishmaniasis

Leishmaniasis is a parasitic disease spread by the bite of infected female sandflies. It can affect the skin, mucous membranes, or internal organs. The most serious form, visceral leishmaniasis (VL), damages the liver, spleen, bone marrow, and kidneys, and is caused mainly by Leishmania donovani and Leishmania infantum.

Every year, 1–2 million people are affected, with over 90% of cases concentrated in just 13 countries. While many infections show no symptoms, untreated VL is usually fatal. Malnutrition, HIV co-infection, genetics, and young age (especially under 5) increase the risk of severe disease.

Dr. Regina Barzilay: From Patient to Pioneer

Dr. Regina Barzilay, a professor at MIT and a pioneer in artificial intelligence (AI), is not only moving the needle in science and technology – she is rebuilding the compass. Her work not only advances medical technology but also challenges how we think about diagnosis, treatment, and the human experience behind each.

Barzilay’s journey into medical AI did not begin in a lab. It began in a hospital room in 2014, when she received a breast cancer diagnosis. For most, that moment signals a personal battle. For her, it became something more. It became the beginning of a mission to reimagine cancer care through machine learning.

Six Ways AI is Transforming Healthcare

With 4.5 billion people currently without access to essential healthcare services and a health worker shortage of 11 million expected by 2030, AI has the potential to help bridge that gap and revolutionize global healthcare.

It could even get us back on track to meet the United Nations’ Sustainable Development Goal of achieving universal health coverage by 2030.

But while the technology is rapidly developing, healthcare is “below average” in its adoption of AI compared to other industries, according to the World Economic Forum’s white paper, The Future of AI-Enabled Health: Leading the Way.

Health care technology trends 2025

What is the future of AI in health care? What is the future of RPM? Is telehealth increasing or decreasing? How can AI reduce physician burnout?

This video from the American Medical Association, featuring a discussion between Margaret Lozovatsky, MD, vice president of Digital Health Innovations, and Todd Unger, CXO, answers all of these questions.

Mamy Ingabire: Transforming Vector Control in Africa

Mamy Ingabire is an entrepreneur dedicated to using cutting-edge technology to address critical challenges across various industries.

As the Managing Director of Charis UAS, Rwanda’s first licensed drone company, she has played a fundamental role in advancing the use of Unmanned Aerial Vehicles (UAVs) to improve efficiency in vector control, agriculture, construction, mapping, healthcare, and more. Under her leadership, Charis UAS has leveraged drone technology to revolutionize data collection and digital solutions.

Drones vs. Mosquitoes: Fighting malaria in Malawi

In the middle of a muddy field next to a reservoir in north-western Malawi, a team of scientists are hard at work. Boxes of equipment lie scattered around a patch of dry ground, where a scientist programmes an automated drone flight into a laptop perched on a metal box. The craggy peak of Linga Mountain (‘watch from afar’ in the local language) looms over the lake, casting its reflection in the water.

With a high-pitched whirr of rotor blades, the drone takes off and starts following the shoreline, taking photos as it goes. Once the drone is airborne, the team switch from high-tech to low-tech mode. They collect ladles, rulers and plastic containers and squelch through mud until they reach the water’s edge.

The Drone Edge in Vector Control

Achieving global vector control’s potential requires “realigning programs to optimize the delivery of interventions that are tailored to the local context [and]…strengthened monitoring systems and novel interventions with proven effectiveness.” This includes “integration of non-chemical and chemical vector control methods [and] evidence-based decision making guided by operational research and entomological and epidemiological surveillance and evaluation.”

Drones or “unmanned aerial vehicles” (UAVs) can save time and money compared to conventional ground-based surveys. Sophisticated models and monitoring equipment can be purchased for a few thousand dollars. They don’t require a pilot’s license, they are becoming easier to fly, and their paths can be fully automated through AI, machine learning, global positioning systems, and computer vision.